Groundbreaking research suggests the shingles vaccine may significantly reduce the risk of heart attacks and strokes in adults.
A global study revealed an 18% lower risk of these events for adults aged 18 and over following vaccination.
This surprising finding warrants further investigation to understand the underlying mechanisms and confirm these results.
Experts emphasize the need for more research before widespread recommendations for younger age groups can be made.
